SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) announced SG Austria has appointed Dr. Stephen Rhind as a consultant to lead its business development activities and finalize pending contracts with major pharmaceutical companies that are currently in their pipeline. Dr. Rhind was selected for having a 28-year track record of achievement in negotiating multimillion dollar contracts with major biotechnology and pharmaceutical companies including GSK (GSK), Onyx Pharmaceuticals, Inc. (ONXX) and Enzon Pharmaceuticals, Inc. (ENZN).
